Article
Combination strategies to promote sensitivity to cytarabine-induced replication stress in acute myeloid leukemia with and without DNMT3A mutations.
Experimental hematology - 1 Jun 2022
Shabashvili Daniil E, Feng Yang, Kaur Prabhjot, Venugopal Kartika, Guryanova Olga A
Abstract excerpt
Cytarabine and other chain-terminating nucleoside analogs that damage replication forks in rapidly proliferating cells are a cornerstone of leukemia chemotherapy, yet the outcomes remain unsatisfactory because of resistance and toxicity. Better understanding of DNA damage repair and downstream effector mechanisms in different disease subtypes can guide combination strategies that sensitize leukemia cells to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
